Projects and Grants per year
Search results
-
Active
A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Live
Grigorian, A. (PI)
Pharmaceutical Research Associates
1/31/22 → 1/16/26
Project: Research project
-
The Role of Crypt Fissioning in IBD Ulcer Healing
Barrett, T. (PI), Beyer, R. (CoI), Chaiswing, L. (CoI), Flomenhoft, D. (CoI), Gao, T. (CoI), Goretsky, T. (CoI), Harrison, D. (CoI), Kapur, N. (CoI), Lohr, K. (CoI), Sullivan, P. (CoI), Grigorian, A. (Former CoI), Holt, E. (Former CoI), Liu, J. (Former CoI) & Stromberg, A. (Former CoI)
National Institute Diabetes & Digestive & Kidney
2/24/21 → 1/31/26
Project: Research project
-
Finished
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) GS-US-384-1944
Grigorian, A. (PI) & Leyson, C. (Former CoI)
8/1/17 → 8/31/18
Project: Research project
-
A Multicenter, Randomized, Double Blind, Placebo-Controlled Phase III study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
Grigorian, A. (PI) & Leyson, C. (CoI)
10/31/16 → 7/12/21
Project: Research project
-
A Phase 3, Double-Blind, Randomized, Long Term, Placebo-Controlled Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
Grigorian, A. (PI) & Leyson, C. (CoI)
Intercept Pharmaceuticals Incorporated
3/15/16 → 8/8/24
Project: Research project